Scarica l'app Stockscreener
3.21
1.53%
-0.05
Pre-mercato:
3.19
-0.02
-0.62%
Precedente Chiudi:
$3.26
Aprire:
$3.19
Volume 24 ore:
25,020
Relative Volume:
0.29
Capitalizzazione di mercato:
$7.90M
Reddito:
$75,700
Utile/perdita netta:
$-7.23M
Rapporto P/E:
-0.1865
EPS:
-17.2081
Flusso di cassa netto:
$-7.37M
1 W Prestazione:
+1.58%
1M Prestazione:
-13.94%
6M Prestazione:
-47.05%
1 anno Prestazione:
-54.01%
Intervallo 1D:
$3.17
$3.3093
Intervallo di 1 settimana:
$3.15
$3.3093
Portata 52W:
$2.3401
$12.03
Aclarion Inc Stock (ACON) Company Profile
Nome
Aclarion Inc
Settore
Industria
Telefono
833 275 2266
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.21 | 8.03M | 75,700 | -7.23M | -7.37M | -17.21 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc Borsa (ACON) Ultime notizie
Aclarion Inc. Q1 2026 Earnings: EPS Surpasses Estimates as Company Prioritizes Cost ControlsStock Idea Network - Newser
Aclarion (ACON) upgraded to buy: Here's why - MSN
ACON News | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Q1 2026 Earnings: EPS Surpasses Estimates by 15.2%, Pre-Revenue Stage ContinuesEnergy Earnings Report - Newser
ACONW SEC FilingsACLARION INC 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion (ACON) Q1 2026 Earnings: $-1.34 EPS Surges Past $-1.58 EstimatesCommunity Watchlist Picks - Newser
Aclarion (ACON) Upgraded to Buy: Here's Why - Yahoo Finance
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com - Investing.com Nigeria
Why Is Aclarion, Inc. (ACONW) Stock Down Today? - Meyka
Aclarion announces $2.5M stock repurchase plan - MSN
Aclarion (ACON) Crushes Q1 2026 Estimates — EPS $-1.34 Tops ViewsSubscription Growth - newser.com
Aclarion, Inc. (ACON) reports Q1 loss, misses revenue estimates - MSN
Aclarion sees net loss but strengthens cash position - BizWest
ACON SEC FilingsAclarion Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Aclarion, Inc. 1Q 2026: Revenue $21.1K, EPS $(1.34) — 10-Q Summary - TradingView
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aclarion (NASDAQ: ACON) widens Q1 2026 loss but boosts cash with $10.4M raise - Stock Titan
Insider Move: Aclarion Director Makes Bold New Share Purchase - TipRanks
Aclarion director Scott Breidbart acquires $18,011 in stock - Investing.com
Aclarion director Scott Breidbart acquires $18,011 in stock By Investing.com - Investing.com India
Director at Aclarion (ACON) buys 5,664 Common Stock shares in public trade - Stock Titan
Aclarion director David Neal buys $7,750 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David Neal buys $7,750 in company stock - Investing.com
Aclarion (NASDAQ: ACON) director purchases 2,500 shares in open market trade - Stock Titan
TradingKey - TradingKey
Top Executive Makes Bold Insider Move at Aclarion, Inc. - TipRanks
Press Release: Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. - 富途牛牛
Aclarion (ACON) CEO makes open-market share purchase - Stock Titan
What Aclarion (ACON) is doing that smart money tracks (Momentum Building) 2026-05-08Oversold Bounce - newser.com
Aclarion (ACON) director adds 1,562 shares in open-market purchase - Stock Titan
ACONW (Aclarion WT) quarterly update shows limited financial disclosure as investors await complete earnings details.High Interest Stocks - newser.com
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial - Investing.com
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment - The Manila Times
Beverly Hills spine practice joins 300-patient back pain trial - Stock Titan
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine - Orthopedics This Week
Aclarion Grants Inducement Stock Option to New Western U.S. Commercial Director Amid Growing Demand for Nociscan - citybuzz -
Aclarion Grants Commercial Director Stock Options for 75,000 Shares - geneonline.com
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. - The Manila Times
New Western U.S. director gets 17,000-share Aclarion option - Stock Titan
Aclarion establishes second trial agreement with Weill Cornell By Investing.com - Investing.com India
Aclarion Inc Azioni (ACON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aclarion Inc Azioni (ACON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
0.66%
4.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):